LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 4.36 | 84.90 | 710 | 322 | 2.2011 | 2.0126 | MN20160318_Q02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 4.36 | 84.90 | 1 | 322 | 0.0031 | -0.9004 | MN20160318_Q02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 4.36 | 84.90 | 756 | 322 | 2.3437 | 2.1124 | MN20160318_Q02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 6.06 | 84.90 | 2 | 365 | 0.0055 | -0.8313 | MN20160318_Q02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 6.06 | 84.90 | 809 | 365 | 2.2137 | 1.9168 | MN20160318_Q02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 6.06 | 84.90 | 3 | 365 | 0.0082 | -0.7955 | MN20160318_Q02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 6.06 | 84.90 | 839 | 365 | 2.2958 | 1.9677 | MN20160318_Q02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 7.77 | 84.90 | 4 | 411 | 0.0097 | -0.7387 | MN20160318_Q02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 7.77 | 84.90 | 886 | 411 | 2.1545 | 1.8021 | MN20160318_Q02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 7.77 | 84.90 | 6 | 411 | 0.0146 | -0.6878 | MN20160318_Q02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 7.77 | 84.90 | 946 | 411 | 2.3004 | 1.8839 | MN20160318_Q02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 9.47 | 84.90 | 6 | 447 | 0.0134 | -0.6688 | MN20160318_Q02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 9.47 | 84.90 | 1002 | 447 | 2.2395 | 1.7993 | MN20160318_Q02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 9.47 | 84.90 | 3 | 447 | 0.0067 | -0.7519 | MN20160318_Q02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 9.47 | 84.90 | 992 | 447 | 2.2171 | 1.7876 | MN20160318_Q02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 11.18 | 84.90 | 8 | 492 | 0.0162 | -0.6060 | MN20160318_Q02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 11.18 | 84.90 | 1085 | 492 | 2.2037 | 1.7311 | MN20160318_Q02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 11.18 | 84.90 | 12 | 492 | 0.0244 | -0.5377 | MN20160318_Q02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 11.18 | 84.90 | 1092 | 492 | 2.2179 | 1.7381 | MN20160318_Q02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 12.88 | 84.90 | 10 | 531 | 0.0188 | -0.5546 | MN20160318_Q02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 12.88 | 84.90 | 1132 | 531 | 2.1318 | 1.6627 | MN20160318_Q02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 12.88 | 84.90 | 9 | 531 | 0.0169 | -0.5719 | MN20160318_Q02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 12.88 | 84.90 | 1150 | 531 | 2.1657 | 1.6786 | MN20160318_Q02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 14.58 | 84.90 | 12 | 663 | 0.0181 | -0.4830 | MN20160318_Q02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 14.58 | 84.90 | 1226 | 663 | 1.8480 | 1.4601 | MN20160318_Q02 | L17 |